These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25896416)

  • 1. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer.
    Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S
    ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.
    Yamashita T; Araki K; Tomifuji M; Kamide D; Tanaka Y; Shiotani A
    Support Care Cancer; 2015 Jan; 23(1):29-35. PubMed ID: 24943276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
    Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
    Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].
    Mizumachi T; Kano S; Homma A; Akazawa M; Hasegawa C; Shiroishi Y; Okamoto C; Kumagai S; Nishimura M; Takasaki H; Takeda H; Yasuda K; Minatogawa H; Dekura Y; Onimaru R; Shirato H; Fukuda S
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):685-689. PubMed ID: 31164507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
    Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer.
    Lee YJ; Lee CG; Cho BC; Kim GE; Choi HJ; Choi EC; Sohn JH; Kim JH
    Head Neck; 2010 Feb; 32(2):235-43. PubMed ID: 19572288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hangeshashinto (TJ-14) prevents radiation-induced mucositis by suppressing cyclooxygenase-2 expression and chemotaxis of inflammatory cells.
    Kamide D; Yamashita T; Araki K; Tomifuji M; Shiotani A
    Clin Transl Oncol; 2017 Nov; 19(11):1329-1336. PubMed ID: 28516399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
    Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy.
    Valentini V; Marazzi F; Bossola M; Miccichè F; Nardone L; Balducci M; Dinapoli N; Bonomo P; Autorino R; Silipigni S; Giuliani F; Tamanti C; Mele MC; Martorana GE
    J Hum Nutr Diet; 2012 Jun; 25(3):201-8. PubMed ID: 22257023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of percutaneous endoscopic gastrostomy on unplanned treatment interruption and nutritional status in patients undergoing chemoradiotherapy for advanced head and neck cancer.
    Goda M; Jinnouchi O; Takaoka T; Abe K; Tamura K; Nakaya Y; Furukita Y; Takechi H; Tangoku A; Takeda N
    J Med Invest; 2015; 62(3-4):173-6. PubMed ID: 26399343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
    Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
    Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC).
    Guan J; Zhang Y; Li Q; Zhang Y; Li L; Chen M; Xiao N; Chen L
    Oncotarget; 2016 Oct; 7(43):70185-70193. PubMed ID: 27602493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between hematotoxicity and serum albumin level in the treatment of head and neck cancers with concurrent chemoradiotherapy using cisplatin.
    Ishizuka M; Fujimoto Y; Itoh Y; Kitagawa K; Sano M; Miyagawa Y; Ando A; Hiramatsu M; Hirasawa N; Ishihara S; Nakashima T; Yamada K
    Jpn J Clin Oncol; 2011 Aug; 41(8):973-9. PubMed ID: 21693483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
    Harrington K; Berrier A; Robinson M; Remenar E; Housset M; de Mendoza FH; Fayette J; Mehanna H; El-Hariry I; Compton N; Franklin N; Biswas-Baldwin N; Lau M; Legenne P; Kumar R
    Eur J Cancer; 2013 May; 49(7):1609-18. PubMed ID: 23265705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
    Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
    J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.